[{"address1": "2450 Holcombe Blvd", "address2": "MS: BCM251", "city": "Houston", "state": "TX", "zip": "77021", "country": "United States", "phone": "713 400 6400", "website": "https://markertherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Juan F. Vera M.D.", "age": 44, "title": "Co-Founder, CEO, President, Treasurer, Secretary & Director", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 400000, "exercisedValue": 0, "unexercisedValue": 9390}, {"maxAge": 1, "name": "Ms. Elizabeth  Donnelly", "title": "Director of Administration", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Maria-Bernadette  Madel Ph.D.", "age": 34, "title": "Director of Corporate Operations & External Communications", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edmund  Cheung", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Patricia  Allison", "title": "Head of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary  Newman Ph.D.", "age": 65, "title": "Head of Regulatory Affairs", "yearBorn": 1959, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert Z. Florkiewicz Sr., Ph.D.", "title": "Senior Director of Molecular Biology & Virology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.21, "open": 1.2, "dayLow": 1.2, "dayHigh": 1.31, "regularMarketPreviousClose": 1.21, "regularMarketOpen": 1.2, "regularMarketDayLow": 1.2, "regularMarketDayHigh": 1.31, "payoutRatio": 0.0, "beta": 1.454, "forwardPE": -0.8835616, "volume": 101311, "regularMarketVolume": 101311, "averageVolume": 1234896, "averageVolume10days": 130310, "averageDailyVolume10Day": 130310, "bid": 0.9288, "ask": 1.54, "bidSize": 2, "askSize": 2, "marketCap": 14596092, "fiftyTwoWeekLow": 0.95, "fiftyTwoWeekHigh": 5.95, "priceToSalesTrailing12Months": 2.7089643, "fiftyDayAverage": 1.4564, "twoHundredDayAverage": 1.94355, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6229223, "profitMargins": -2.71109, "floatShares": 11028092, "sharesOutstanding": 11314800, "sharesShort": 503060, "sharesShortPriorMonth": 122736, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.044499997, "heldPercentInsiders": 0.07078, "heldPercentInstitutions": 0.26319, "shortRatio": 0.17, "shortPercentOfFloat": 0.3312, "impliedSharesOutstanding": 11314800, "bookValue": 0.927, "priceToBook": 1.3915857, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -14607564, "trailingEps": -1.35, "forwardEps": -1.46, "lastSplitFactor": "1:10", "lastSplitDate": 1674777600, "enterpriseToRevenue": 1.156, "52WeekChange": -0.65135133, "SandP52WeekChange": 0.1513431, "quoteType": "EQUITY", "currentPrice": 1.29, "targetHighPrice": 8.0, "targetLowPrice": 4.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 10461971, "totalCashPerShare": 0.809, "totalDebt": 0, "quickRatio": 2.837, "currentRatio": 3.452, "totalRevenue": 5388071, "revenuePerShare": 0.499, "returnOnAssets": -0.69385004, "returnOnEquity": -1.44678, "grossProfits": -10481809, "freeCashflow": -6802673, "operatingCashflow": -10883735, "revenueGrowth": -0.263, "grossMargins": -1.9453701, "ebitdaMargins": 0.0, "operatingMargins": -4.94788, "financialCurrency": "USD", "symbol": "MRKR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1755903143, "regularMarketTime": 1755892802, "exchange": "NCM", "messageBoardId": "finmb_1725474", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "shortName": "Marker Therapeutics, Inc.", "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 6.61156, "regularMarketPrice": 1.29, "marketState": "CLOSED", "epsTrailingTwelveMonths": -1.35, "epsForward": -1.46, "epsCurrentYear": -1.08, "priceEpsCurrentYear": -1.1944444, "fiftyDayAverageChange": -0.16640007, "fiftyDayAverageChangePercent": -0.11425438, "twoHundredDayAverageChange": -0.65355, "twoHundredDayAverageChangePercent": -0.33626613, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1026826200000, "postMarketChangePercent": -3.8759654, "postMarketPrice": 1.24, "postMarketChange": -0.049999952, "regularMarketChange": 0.0799999, "regularMarketDayRange": "1.2 - 1.31", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1234896, "fiftyTwoWeekLowChange": 0.33999997, "fiftyTwoWeekLowChangePercent": 0.35789472, "fiftyTwoWeekRange": "0.95 - 5.95", "fiftyTwoWeekHighChange": -4.66, "fiftyTwoWeekHighChangePercent": -0.7831933, "fiftyTwoWeekChangePercent": -65.13513, "dividendDate": 1473984000, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "isEarningsDateEstimate": true, "longName": "Marker Therapeutics, Inc.", "displayName": "Marker Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-23"}]